Suppr超能文献

在医护人员检测中,使用咽拭子对阿尔托纳-严重急性呼吸综合征冠状病毒2双靶点逆转录定量聚合酶链反应检测法与商用环介导等温扩增检测法进行直接比较。

Direct comparison of Altona-SARS-CoV-2 dual target RT-qPCR Assay with commercial LAMP Assay using throat washes in health care staff testing.

作者信息

Wanney Johannes, Lüsebrink Jessica, Spölgen Gina, Demuth Sabrina, Schildgen Verena, Schildgen Oliver

机构信息

Institut für Pathologie, Kliniken der Stadt Köln gGmbH, Klinikum der Privaten Universität Witten/Herdecke, Ostmerheimer Str. 200, Cologne D-51109, Germany.

出版信息

J Clin Virol Plus. 2022 Aug;2(3):100088. doi: 10.1016/j.jcvp.2022.100088. Epub 2022 Jun 2.

Abstract

BACKGROUND

Rapid molecular diagnostics by PCR has a crucial role in handling the global SARS-CoV-2 pandemic. As diagnoses are time-sensitive and global supply chains are susceptible to various factors alternative detection methods would be an important backup.

OBJECTIVES

During the study the performance of a commercially available isothermal LAMP method for SARS-CoV-2 detection was compared to a IVD RT-PCR Assays using throat wash specimens that were routinely taken in our hospital setting.

STUDY DESIGN

Throat wash specimens of hospital staff ( = 174) previously tested positive for SARS-CoV-2 by the Altona Diagnostics RealStar SARS-CoV-2 RT-PCR (Altona Diagnostics, Hamburg, Germany) was tested for SARS-CoV-2 also by the SARS-CoV-2 Rapid Colorimetric LAMP Assay (NEB Germany GmbH, Frankfurt a.M., Germany).

RESULTS

The sensitivity of the colorimetric LAMP Assay compared to RT-qPCR was 78.74%, and the specificity was determined to 88.24% with a positive predictive value of 0.986 and a negative predicitve value of 0.882. The positive and negative likelihood ratio for LAMP was 6.693 and 0.241, respectively, while the diagnostic odds ratio was 27.77.

CONCLUSIONS

In times of limited PCR test ressources and in settings with limited PCR capacities, the colorimetric LAMP Assay could serve as an alternative, if a calculable loss of sensitivity is acceptable from the Public Health perspective in certain settings.

摘要

背景

通过聚合酶链反应(PCR)进行快速分子诊断在应对全球严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行中起着关键作用。由于诊断具有时间敏感性,且全球供应链易受各种因素影响,替代检测方法将是重要的备用手段。

目的

在本研究中,将一种用于SARS-CoV-2检测的市售等温环介导等温扩增(LAMP)方法与在我们医院环境中常规采集的咽拭子标本使用的体外诊断逆转录聚合酶链反应(IVD RT-PCR)检测方法的性能进行比较。

研究设计

对医院工作人员(n = 174)的咽拭子标本进行检测,这些标本先前通过阿尔托纳诊断公司的RealStar SARS-CoV-2 RT-PCR(德国汉堡阿尔托纳诊断公司)检测为SARS-CoV-2阳性,同时也通过SARS-CoV-2快速比色LAMP检测(德国美因河畔法兰克福的NEB德国有限公司)检测SARS-CoV-2。

结果

与逆转录定量聚合酶链反应(RT-qPCR)相比,比色LAMP检测的灵敏度为78.74%,特异性为88.24%,阳性预测值为0.986,阴性预测值为0.882。LAMP的阳性和阴性似然比分别为6.693和0.241,而诊断比值比为27.77。

结论

在聚合酶链反应(PCR)检测资源有限且PCR能力有限的情况下,如果从公共卫生角度在某些情况下可接受一定程度的灵敏度损失,比色LAMP检测可作为一种替代方法。

相似文献

5
Rapid and Reliable Detection of SARS-CoV-2 Using Direct RT-LAMP.
Diagnostics (Basel). 2022 Mar 28;12(4):828. doi: 10.3390/diagnostics12040828.
8
Development of a colorimetric RT-LAMP assay for the detection of SARS-COV-2 isolated from Oman.
J Infect Dev Ctries. 2022 Jun 30;16(6):952-958. doi: 10.3855/jidc.15377.
10
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis.
J Clin Virol. 2020 Nov;132:104616. doi: 10.1016/j.jcv.2020.104616. Epub 2020 Aug 31.

引用本文的文献

1
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.

本文引用的文献

4
Detection of SARS-CoV-2 Infection in Gargle, Spit, and Sputum Specimens.
Microbiol Spectr. 2021 Sep 3;9(1):e0003521. doi: 10.1128/Spectrum.00035-21. Epub 2021 Aug 25.
5
The role of mouthwash sampling in SARS-CoV-2 diagnosis.
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2199-2206. doi: 10.1007/s10096-021-04320-4. Epub 2021 Aug 3.
7
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2.
8
ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing.
Expert Rev Mol Diagn. 2021 Apr;21(4):349-362. doi: 10.1080/14737159.2021.1902311. Epub 2021 Mar 24.
10
Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective.
Pathogens. 2021 Jan 5;10(1):38. doi: 10.3390/pathogens10010038.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验